Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ascension Health
Providers
JPM26: Ascension's ASC megadeal opens new markets, partnerships
New CEO Eduardo Conrado outlined the upsides of Ascension's pending $3.9 billion acquisition of AmSurg at the J.P. Morgan Healthcare Conference.
Dave Muoio
Jan 15, 2026 4:00pm
2026 Outlook: Exit interviews with retiring healthcare CEOs
Dec 24, 2025 6:00am
Ascension credits operating discipline for $133M Q1 improvement
Nov 3, 2025 4:00pm
How states are thinking about CMS' $50B rural health fund
Oct 3, 2025 5:00pm
Judge greenlights Ascension cybersecurity class action
Sep 25, 2025 1:00pm
Ascension trims operating losses by $1.3B in fiscal 2025
Sep 18, 2025 10:27am
